Overview

Study Evaluating the Effect of Lecozotan SR on the QTc Interval

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo- and moxifloxacin (open-label)-controlled, 4-period crossover study.
Phase:
Phase 1
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination